"The
Report Degenerative Disc Disease - Pipeline Review, H1 2017 provides
information on pricing, market analysis, shares, forecast, and
company profiles for key industry participants. -
MarketResearchReports.biz"
Global
Markets Direct's latest Pharmaceutical and Healthcare disease
pipeline guide Degenerative Disc Disease Pipeline Review, H1 2017,
provides an overview of the Degenerative Disc Disease
(Musculoskeletal Disorders) pipeline landscape.
Degenerative
disc disease is refers to degeneration of intervertebral discs of the
spinal column. The main symptom of degenerative disc disease is pain,
which often worsens during certain types of activity. Predisposing
factors include aging and injury or trauma. Treatment includes
non-steroidal anti-inflammatory drugs, muscle relaxants, pain
relievers and antidepressants.
View Report @
http://www.marketresearchreports.biz/analysis/1021124
Report
Highlights
Global
Markets Direct's Pharmaceutical and Healthcare latest pipeline guide
Degenerative Disc Disease Pipeline Review, H1 2017, provides
comprehensive information on the therapeutics under development for
Degenerative Disc Disease (Musculoskeletal Disorders), complete with
analysis by stage of development, drug target, mechanism of action
(MoA), route of administration (RoA) and molecule type. The guide
covers the descriptive pharmacological action of the therapeutics,
its complete research and development history and latest news and
press releases.
The
Degenerative Disc Disease (Musculoskeletal Disorders) pipeline guide
also reviews of key players involved in therapeutic development for
Degenerative Disc Disease and features dormant and discontinued
projects. The guide covers therapeutics under Development by
Companies /Universities /Institutes, the molecules developed by
Companies in Phase III, Phase II, Phase I, IND/CTA Filed,
Preclinical, Discovery and Unknown stages are 1, 5, 1, 1, 5, 1 and 1
respectively. Similarly, the Universities portfolio in Discovery
stages comprises 1 molecules, respectively.
Degenerative
Disc Disease (Musculoskeletal Disorders) pipeline guide helps in
identifying and tracking emerging players in the market and their
portfolios, enhances decision making capabilities and helps to create
effective counter strategies to gain competitive advantage. The guide
is built using data and information sourced from Global Markets
Directs proprietary databases, company/university websites, clinical
trial registries, conferences, SEC filings, investor presentations
and featured press releases from company/university sites and
industry-specific third party sources. Additionally, various dynamic
tracking processes ensure that the most recent developments are
captured on a real time basis.
Get
Sample Copy Of This Report @
Scope
-
The pipeline guide provides a snapshot of the global therapeutic
landscape of Degenerative Disc Disease (Musculoskeletal Disorders).
-
The pipeline guide reviews pipeline therapeutics for Degenerative
Disc Disease (Musculoskeletal Disorders) by companies and
universities/research institutes based on information derived from
company and industry-specific sources.
-
The pipeline guide covers pipeline products based on several stages
of development ranging from pre-registration till discovery and
undisclosed stages.
-
The pipeline guide features descriptive drug profiles for the
pipeline products which comprise, product description, descriptive
licensing and collaboration details, R&D brief, MoA & other
developmental activities.
-
The pipeline guide reviews key companies involved in Degenerative
Disc Disease (Musculoskeletal Disorders) therapeutics and enlists all
their major and minor projects.
-
The pipeline guide evaluates Degenerative Disc Disease
(Musculoskeletal Disorders) therapeutics based on mechanism of action
(MoA), drug target, route of administration (RoA) and molecule type.
-
The pipeline guide encapsulates all the dormant and discontinued
pipeline projects.
-
The pipeline guide reviews latest news related to pipeline
therapeutics for Degenerative Disc Disease (Musculoskeletal
Disorders)
Reasons
to buy
-
Procure strategically important competitor information, analysis, and
insights to formulate effective R&D strategies.
-
Recognize emerging players with potentially strong product portfolio
and create effective counter-strategies to gain competitive
advantage.
-
Find and recognize significant and varied types of therapeutics under
development for Degenerative Disc Disease (Musculoskeletal
Disorders).
-
Classify potential new clients or partners in the target demographic.
-
Develop tactical initiatives by understanding the focus areas of
leading companies.
-
Plan mergers and acquisitions meritoriously by identifying key
players and its most promising pipeline therapeutics.
-
Formulate corrective measures for pipeline projects by understanding
Degenerative Disc Disease (Musculoskeletal Disorders) pipeline depth
and focus of Indication therapeutics.
-
Develop and design in-licensing and out-licensing strategies by
identifying prospective partners with the most attractive projects to
enhance and expand business potential and scope.
-
Adjust the therapeutic portfolio by recognizing discontinued projects
and understand from the know-how what drove them from pipeline.
Table
Of Contents :
List
of Tables
List
of Figures
Introduction
Global
Markets Direct Report Coverage
Degenerative
Disc Disease - Overview
Degenerative
Disc Disease - Therapeutics Development
Pipeline
Overview
Pipeline
by Companies
Pipeline
by Universities/Institutes
Products
under Development by Companies
Products
under Development by Universities/Institutes
Degenerative
Disc Disease - Therapeutics Assessment
Assessment
by Target
Assessment
by Mechanism of Action
Assessment
by Route of Administration
Assessment
by Molecule Type
Degenerative
Disc Disease - Companies Involved in Therapeutics Development
AnGes
MG Inc
Biogenomics
Ltd
Biopharm
GmbH
BioRestorative
Therapies Inc
Bone
Therapeutics SA
DiscGenics
Inc
ISTO
Technologies Inc
Osiris
Therapeutics Inc
Samumed
LLC
TissueGene
Inc
U.S.
Stem Cell Inc
Yuhan
Corp
Degenerative
Disc Disease - Drug Profiles
AdipoCell
- Drug Profile
Product
Description
Mechanism
Of Action
R&D
Progress
ALLOB
- Drug Profile
Product
Description
Mechanism
Of Action
R&D
Progress
AMG-0101
- Drug Profile
Product
Description
Mechanism
Of Action
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment